These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1733106)
1. HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect. Hirsch I; Salaun D; Brichacek B; Chermann JC Virology; 1992 Feb; 186(2):647-54. PubMed ID: 1733106 [TBL] [Abstract][Full Text] [Related]
2. Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1. Yahi N; Fantini J; Hirsch I; Chermann JC Arch Virol; 1992; 125(1-4):287-98. PubMed ID: 1642554 [TBL] [Abstract][Full Text] [Related]
3. The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant. Spire B; Hirsch I; Neuveut C; Sire J; Chermann JC Virology; 1990 Aug; 177(2):756-8. PubMed ID: 2371777 [TBL] [Abstract][Full Text] [Related]
4. Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR). Hirsch I; Spire B; Tsunetsugu-Yokota Y; Neuveut C; Sire J; Chermann JC Virology; 1990 Aug; 177(2):759-63. PubMed ID: 2371778 [TBL] [Abstract][Full Text] [Related]
5. Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK. De Mareuil J; Salaun D; Chermann JC; Hirsch I Virology; 1995 Jun; 209(2):649-53. PubMed ID: 7778297 [TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain. de Mareuil J; Brichacek B; Salaun D; Chermann JC; Hirsch I J Virol; 1992 Nov; 66(11):6797-801. PubMed ID: 1357191 [TBL] [Abstract][Full Text] [Related]
7. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Spire B; Sire J; Zachar V; Rey F; Barré-Sinoussi F; Galibert F; Hampe A; Chermann JC Gene; 1989 Sep; 81(2):275-84. PubMed ID: 2806917 [TBL] [Abstract][Full Text] [Related]
8. Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages. Schmidtmayerova H; Bolmont C; Baghdiguian S; Hirsch I; Chermann JC Virology; 1992 Sep; 190(1):124-33. PubMed ID: 1382338 [TBL] [Abstract][Full Text] [Related]
9. Restriction of HIV-1 replication in intestinal cells is genetically controlled by the gag-pol region of the HIV-1 genome. De Mareuil J; Guettari N; Bolmont C; Salaun D; Baillon JG; Hostomsky Z; Hirsch I Virology; 1995 Feb; 207(1):160-7. PubMed ID: 7532883 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. Venaud S; Yahi N; Fehrentz JL; Guettari N; Nisato D; Hirsch I; Chermann JC Res Virol; 1992; 143(5):311-9. PubMed ID: 1480823 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 infectivity of human carcinoma cell lines lacking CD4 receptors. Brichacek B; Derderian C; Chermann JC; Hirsch I Cancer Lett; 1992 Mar; 63(1):23-31. PubMed ID: 1313332 [TBL] [Abstract][Full Text] [Related]
12. Genetic control of infection of primary macrophages with T-cell-tropic strains of HIV-1. Hirsch I; de Mareuil J; Salaun D; Chermann JC Virology; 1996 May; 219(1):257-61. PubMed ID: 8623536 [TBL] [Abstract][Full Text] [Related]
13. Replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1)/simian immunodeficiency virus agm3 chimeric viruses in human and monkey cells: the 5' half of the HIV-1 genome is responsible for virus cytopathogenicity. Jin M; Ido E; Kuwata T; Igarashi T; Cichutek K; Kurth R; Miura T; Enose Y; Chen J; Hayami M J Gen Virol; 1996 Oct; 77 ( Pt 10)():2427-31. PubMed ID: 8887473 [TBL] [Abstract][Full Text] [Related]
14. Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. Tebit DM; Zekeng L; Kaptué L; Salminen M; Kräusslich HG; Herchenröder O AIDS Res Hum Retroviruses; 2002 Jan; 18(1):39-48. PubMed ID: 11804555 [TBL] [Abstract][Full Text] [Related]
15. Human endothelial cells isolated from the hepatic sinusoids and the umbilical vein display a different permissiveness for HIV1. Lafon ME; Gendrault JL; Royer C; Jaeck D; Kirn A; Steffan AM Res Virol; 1993; 144(1):99-104. PubMed ID: 8446785 [TBL] [Abstract][Full Text] [Related]
16. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells. Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467 [TBL] [Abstract][Full Text] [Related]
18. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. Pietschmann T; Zentgraf H; Rethwilm A; Lindemann D J Virol; 2000 May; 74(10):4474-82. PubMed ID: 10775583 [TBL] [Abstract][Full Text] [Related]
19. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. Shieh JT; Martín J; Baltuch G; Malim MH; González-Scarano F J Virol; 2000 Jan; 74(2):693-701. PubMed ID: 10623731 [TBL] [Abstract][Full Text] [Related]
20. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties. Pancino G; Castelot S; Sonigo P Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]